The combination of ipratropium and albuterol is prescribed to help patients control the symptoms of various lung diseases such as asthma, chronic bronchitis, and emphysema.
Asthma is a chronic inflammatory condition that narrows and irritates the lungs' airways. Asthma is a prevalent but non-contagious respiratory disease that usually begins in childhood and continues into adulthood. Asthma may vary in severity from person to person.
Chronic obstructive pulmonary disease is an umbrella term for several diseases that cause airflow blockage and difficulty with breathing. Emphysema and chronic bronchitis are the most common diseases classified under COPD.
Chronic bronchitis is long-term inflammation of the bronchioles and is characterized by productive coughing that occurs over several months to years. Chronic bronchitis may be caused by smoking tobacco products, air pollution, or allergens and may lead to COPD.
Emphysema is a condition that occurs when the air sacs in your lungs have become damaged. This can be caused by smoking, inhaling harmful chemicals, or regular exposure to air pollution. Emphysema is most commonly characterized by chronic shortness of breath that can lead to additional adverse symptoms.
These diseases cause similar symptoms, including:
- Chest tightness
- Shortness of breath
- Difficulty breathing
- Coughing
- Wheezing